Oncor loses patent fight with University of California:
This article was originally published in Clinica
Executive Summary
A San Francisco court has found that Oncor's Coatosome products violated a University of California patent for chromosome imaging. Another UC claim - concerning Oncor's Inform HER-2/neu gene amplification detection system - was dismissed. Oncor claims Coatosome represents less than 5% of its sales. UC had licensed the technology to rival Vysis. Oncor says that it will "vigorously pursue various legal alternatives" in the litigation.